Praful Bohra

Rediff.com » News » Praful Bohra

News for Praful Bohra

Business

Ranbaxy's Lipitor generic may miss Dec deadline for return to US market

Ranbaxy's generic version of Lipitor, which faced recall from the US market last month, could remain missing at the beginning of 2013, if the company fails to resume supplies of the drug by the end......

Cipla rejigs China investment to focus on niche verticals

Drug maker Cipla Ltd is rejigging its China business. The pharma company recently exited a significant part of its investment in its Chinese partner Desano Holdings, while ploughing back a part of......

US regulator tightens drug approval norms

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of genericsPharmaceutical companies operating in the US might be in for a......

Indian drug makers face heat of US regulator's crackdown

Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past......

Wait for Indian generic launches gets longer

Indian generic drug makers, such as Ranbaxy, Lupin, Dr Reddy's and Aurobindo, which often opt to challenge patents in the US, might have to wait longer to launch their generic versions there. For......

Rediff News

Praful Bohra

News for Praful Bohra

Ranbaxy's Lipitor generic may miss Dec deadline for return to US market

Cipla rejigs China investment to focus on niche verticals

US regulator tightens drug approval norms

Indian drug makers face heat of US regulator's crackdown

Wait for Indian generic launches gets longer

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS